Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Collection of Lung Malignant Tissue for the Validation of a Novel Technology to Identify Oncogenic Mutations and Personalized Medicine

NCT02274025 is registered in ClinicalTrials.gov with Fore Biotherapeutics as lead sponsor.

NCT NCT02274025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02274025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Collection of Lung Malignant Tissue for the Validation of a Novel Technology to Identify Oncogenic Mutations and Personalized Medicine
Lead sponsor
Fore Biotherapeutics
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
October 31, 2016
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer